Anthony Fiore | Associate Director
Centers for Disease Control and Prevention

Anthony Fiore, Associate Director, Centers for Disease Control and Prevention

Anthony (Tony) Fiore, MD, MPH, is a medical epidemiologist and infectious diseases physician who has worked at CDC for 25 years. Since January 2015, he has been Chief of the Epidemiology Research and Innovations Branch (ERIB), Division of Healthcare Quality Promotion, leading projects aimed at preventing or reducing healthcare-associated infections, antibiotic resistance, and sepsis. ERIB leads and supports collaborative work with the 11 CDC Prevention Epicenters, the Modeling Infectious Diseases in Healthcare program and the Emerging Infections Program’s active, population-based HAI surveillance and research programs in 10 states, as well as intramural research on HAIs and sepsis using administrative and electronic medical record datasets. He serves on a CDC Institutional Review Board, the Society for Healthcare Epidemiology of America’s publications committee, and is an Associate Editor for the journal Emerging Infectious Diseases. Previous work at CDC has focused on vaccine preventable diseases including respiratory diseases (pneumococcal infection and influenza) and viral hepatitis. Other experience includes malaria prevention in Africa, and emergency responses for anthrax, SARS, cholera, and Ebola. He recently served as CDC representative to the Vaccine Incentives workgroup formed by the Presidential Advisory Council on Combating Antibiotic Resistance (PACCARB), and presented sessions to external advisory committees on vaccines against healthcare associated infections and antibiotic resistance to CDC’s Healthcare Infection Control Practices Advisory Committee and the Advisory Committee on Immunization Practices. He is currently on the board of the Wellcome Trust’s Surveillance and Epidemiology of Drug-Resistant Infections Consortium (SEDRIC), and on the WHO Technical Expert Group formed in 2019 and focused on use of vaccines for combatting antibiotic resistance (VAC-AMR).


Pre-congress Workshops, April 6 @ 10:00


Harmonizing national and international priorities – what is the role of public health and government in implementation AMR efforts? Collaborative strategies from industry to halting the AMR crisis – do we have a consistent message? 10:00 Workshop leader opening remarks10:10 Vaccines as Another Strategy to Reduce Antibiotic Resistance in Healthcare Settings10:40 Gaps in veterinary vaccines to address AMR11:10 Why do we think this is possible? Update on vaccine technology that is enabling better vaccinesPipeline updates from biotech and industry – alternatives from antibiotics11:40 TB vaccines12:10 Bacterial Vaccine Polypeptides12:25 Vaccine efforts in Acinetobacter baumannii12:40 Update on the development of a Klebsiella and Pseudomonas vaccine
last published: 05/Mar/20 10:35 GMT

back to speakers

Sign Up for Event Updates